Leonard Gomella, MD, shares his insight on the recent FDA approvals and other ongoing progress in the treatment of patients with prostate cancer.
Original Article: Gomella Discusses Apalutamide Approval and Other Progress in Prostate Cancer
NEXT ARTICLE